|
1
|
Tzouvelekis LS, Markogiannakis A,
Psichogiou M, Tassios PT and Daikos GL: Carbapenemases in
Klebsiella pneumoniae and other Enterobacteriaceae: An evolving
crisis of global dimensions. Clin Microbiol Rev. 25:682–707. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Karaiskos I and Giamarellou H:
Multidrug-resistant and extensively drug-resistant Gram-negative
pathogens: Current and emerging therapeutic approaches. Expert Opin
Pharmacother. 15:1351–1370. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nordmann P, Cuzon G and Naas T: The real
threat of Klebsiella pneumoniae carbapenemase-producing bacteria.
Lancet Infect Dis. 9:228–236. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tenover FC, Kalsi RK, Williams PP, Carey
RB, Stocker S, Lonsway D, Rasheed JK, Biddle JW, McGowan JE Jr and
Hanna B: Carbapenem resistance in Klebsiella pneumoniae not
detected by automated susceptibility testing. Emerg Infect Dis.
12:1209–1213. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Anderson KF, Lonsway DR, Rasheed JK,
Biddle J, Jensen B, McDougal LK, Carey RB, Thompson A, Stocker S,
Limbago B and Patel JB: Evaluation of methods to identify the
Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin
Microbiol. 45:2723–2725. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Naas T, Cuzon G, Truong HV and Nordmann P:
Role of ISKpn7 and deletions in blaKPC gene expression. Antimicrob
Agents Chemother. 56:4753–4759. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kitchel B, Rasheed JK, Endimiani A, Hujer
AM, Anderson KF, Bonomo RA and Patel JB: Genetic factors associated
with elevated carbapenem resistance in KPC-producing Klebsiella
pneumoniae. Antimicrob Agents Chemother. 54:4201–4207. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pages JM, Peslier S, Keating TA, Lavigne
JP and Nichols WW: Role of the outer membrane and porins in
susceptibility of β-lactamase-producing enterobacteriaceae to
ceftazidime--avibactam. Antimicrob Agents Chemother. 60:1349–1359.
2016. View Article : Google Scholar :
|
|
9
|
Landman D, Bratu S and Quale J:
Contribution of OmpK36 to carbapenem susceptibility in
KPC-producing Klebsiella pneumoniae. J Med Microbiol. 58:1303–1308.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin XM, Yang JN, Peng XX and Li H: A novel
negative regulation mechanism of bacterial outer membrane proteins
in response to antibiotic resistance. J Proteome Res. 9:5952–5959.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Santajit S and Indrawattana N: Mechanisms
of antimicrobial resistance in ESKAPE pathogens. Biomed Res Int.
2016:24750672016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Saw HT, Webber MA, Mushtaq S, Woodford N
and Piddock LJ: Inactivation or inhibition of AcrAB-TolC increases
resistance of carbapenemase-producing Enterobacteriaceae to
carbapenems. J Antimicrob Chemother. 71:1510–1519. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Roth AL, Kurpiel PM, Lister PD and Hanson
ND: bla(KPC) RNA expression correlates with two transcriptional
start sites but not always with gene copy number in four genera of
Gram-negative pathogens. Antimicrob Agents Chemother. 55:3936–3938.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liang W, Xie Y, Xiong W, Tang Y, Li G,
Jiang X and Lu Y: Anti-restriction protein, KlcAHS, promotes
dissemination of carbapenem resistance. Front Cell Infect
Microbiol. 7:1502017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Serfiotis-Mitsa D, Herbert AP, Roberts GA,
Soares DC, White JH, Blakely GW, Uhrín D and Dryden DT: The
structure of the KlcA and ArdB proteins reveals a novel fold and
antirestriction activity against Type I DNA restriction systems in
vivo but not in vitro. Nucleic Acids Res. 38:1723–1737. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gust B, Challis GL, Fowler K, Kieser T and
Chater KF: PCR-targeted Streptomyces gene replacement identifies a
protein domain needed for biosynthesis of the sesquiterpene soil
odor geosmin. Proc Natl Acad Sci USA. 100:1541–1546. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang Y, Werling U and Edelmann W:
Seamless Ligation Cloning Extract (SLiCE) cloning method. Methods
Mol Biol. 1116:235–244. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Derbise A, Lesic B, Dacheux D, Ghigo JM
and Carniel E: A rapid and simple method for inactivating
chromosomal genes in Yersinia. FEMS Immunol Med Microbiol.
38:113–116. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Methods for antimicrobial susceptibility
testing of anaerobic bacteria. 9th. CLSI standard M11. Clinical and
Laboratory Standards Institute; Wayne, PA: 2018
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Marchaim D, Navon-Venezia S, Schwaber MJ
and Carmeli Y: Isolation of imipenem-resistant Enterobacter
species: Emergence of KPC-2 carbapenemase, molecular
characterization, epidemiology, and outcomes. Antimicrob Agents
Chemother. 52:1413–1418. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Elliott E, Brink AJ, van Greune J, Els Z,
Woodford N, Turton J, Warner M and Livermore DM: In vivo
development of ertapenem resistance in a patient with pneumonia
caused by Klebsiella pneumoniae with an extended-spectrum
beta-lactamase. Clin Infect Dis. 42:e95–e98. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jacoby GA, Mills DM and Chow N: Role of
beta-lactamases and porins in resistance to ertapenem and other
beta-lactams in Klebsiella pneumoniae. Antimicrob Agents Chemother.
48:3203–3206. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lartigue MF, Poirel L, Poyart C,
Reglier-Poupet H and Nordmann P: Ertapenem resistance of
Escherichia coli. Emerg Infect Dis. 13:315–317. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Szabo D, Silveira F, Hujer AM, Bonomo RA,
Hujer KM, Marsh JW, Bethel CR, Doi Y, Deeley K and Paterson DL:
Outer membrane protein changes and efflux pump expression together
may confer resistance to ertapenem in Enterobacter cloacae.
Antimicrob Agents Chemother. 50:2833–2835. 2006. View Article : Google Scholar : PubMed/NCBI
|
